Search for stocks /

Sharda Cropchem Ltd Q2FY26 | ₹929 Cr Sales, ₹74 Cr PAT – The Pesticide Exporter That Outsourced Its Factories But Not Its Problems


1. At a Glance

Welcome to Sharda Cropchem Ltd (SCL) — the company that exports pesticides without owning a single pesticide factory. Trading at ₹884 (down 7.3% because the market loves drama), it flaunts a market cap of ₹7,974 crore, a P/E of 17.6, and an ROCE of 16.5%. In Q2FY26, revenue rose 19.6% YoY to ₹929 crore, and PAT jumped 75% YoY to ₹74.3 crore — a rare sight in a sector that’s been hit harder than farmers’ patience during monsoon delays.

Annual revenue for FY25 stood at ₹4,672 crore, with PAT at ₹452 crore, an EPS of ₹50, and margins rebounding to 16.4% OPM from last year’s depressing 10%. The company is nearly debt-free (₹3.9 crore debt), has a book value of ₹297, and still yields a modest 1.02% dividend, proving that they at least remember shareholders exist.

But the story isn’t all sunshine and spray nozzles — tax notices of ₹180 crore, capex of ₹450 crore on registration dossiers, and a CFO resignation in 2023 keep this agrochemical exporter on its toes. In short: Sharda Cropchem is the desi version of “license to spray,” where the licenses make more money than the factories.


2. Introduction

If Bollywood ever made a biopic called The Outsourced Alchemist, it would be based on Sharda Cropchem. Founded by Sharda and R.V. Bubna, this Mumbai-based company turned chemical trading into a full-fledged export empire — all without manufacturing a single drop of pesticide.

Its business model is so light it could float on a molecule — identify generic agrochemicals, secure global registrations (the real treasure), outsource production, and sell worldwide. It’s the Amazon aggregator model of the pesticide world: low assets, high dossiers, and a margin for every molecule.

In FY24, the entire agrochemical sector took a beating — global distributors were sitting on warehouses full of unsold herbicides, and Chinese supply chains dumped cheap actives. Yet, Sharda somehow held its ground. Now, FY25 and FY26 show recovery signs — volume growth up 20%, pricing improving, and European demand reviving faster than you can say “fungicide.”

And unlike big boys like UPL or PI Industries who spend billions on factories, Sharda’s focus is paperwork — it holds 2,934 registrations and 1,034 pending applications. In the chemical world, registrations are like Netflix licenses — the more you have, the more markets you can invade.

So, while others are mixing chemicals, Sharda is mixing strategies.


3. Business Model – WTF Do They Even Do?

Simple answer: Sharda Cropchem is a global exporter of agrochemicals (fungicides, herbicides, insecticides) and non-agro products like conveyor belts, dyes, and rubber sheets. Complex answer: it’s a legal hacker of the agrochemical licensing system.

Here’s how the magic works:

  1. Identify molecules going off-patent.
  2. Register them in various countries (that’s the expensive, brainy part).
  3. Outsource production to third-party manufacturers.
  4. Sell the products under its brand or white-label to distributors across 80+ countries.

The result? Asset-light, high-margin, low-risk model — unless regulators wake up one fine morning.

Business Split (FY25):

  • Agrochemicals – 82% of revenue (Herbicides 56%, Fungicides 22%, Insecticides 22%)
  • Non-Agro – 18% of revenue (Conveyor belts, dyes, intermediates)

Geographically, Sharda is Europe-heavy (64% of agro revenue), followed by NAFTA (20%) and LATAM (9%). If you think it sounds risky to depend on Europe, you’re right — but it’s also the region that pays on time.

The company works with 525 distributors and a sales team of 500+, which means its employees are likely spending more time explaining EU regulations than visiting farms.

So yes, Sharda doesn’t make chemicals — it makes money out of those who do.


4. Financials Overview

MetricQ2FY26 (Latest)Q2FY25 (YoY)Q1FY26 (QoQ)YoY %QoQ %
Revenue (₹ Cr)929777985+19.6%-5.7%
EBITDA (₹ Cr)13390215+47.8%-38.1%
PAT (₹ Cr)74.342143+76.9%-48.1%
EPS (₹)8.244.7015.83+75.3%-48.0%

Annualised EPS = ₹8.24 × 4 = ₹32.96 → Implied P/E = 26.8x

Commentary:
The Q2 numbers show a strong comeback — double-digit growth, better realizations, and margin restoration. But sequentially, profits dipped after a blockbuster Q1 (normal for a seasonal agrochemical exporter). At least this time, Sharda didn’t report negative operating profit like the FY24 horror show.


5. Valuation Discussion – Fair Value Range

Let’s decode the “is this cheap or just lazy?” question:

(a) P/E Method

  • Annualised EPS: ₹50.1
Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!